My issue is less with the technology and it’s large promise, and more with how vaccine testing and rollout has been botched or unnecessarily slowed down at every level.
I agree that the main issue is regulation that makes vaccine testing and the rollout harder then it needs to be.
We don’t know at this point how often you can give someone polyethylenglycol-based mRNA without their body creating a serious allergic reaction against it. That’s an open safety question that needs to be addressed before you can use mRNA treatments to address a host of different issues. We already have substantially more side effects for the second vaccine dose then the first.
I agree that the main issue is regulation that makes vaccine testing and the rollout harder then it needs to be.
We don’t know at this point how often you can give someone polyethylenglycol-based mRNA without their body creating a serious allergic reaction against it. That’s an open safety question that needs to be addressed before you can use mRNA treatments to address a host of different issues. We already have substantially more side effects for the second vaccine dose then the first.